Genmab — December 2018

[E_L]

in addition to that; it is a pilot program; i believe they will try this out with the Big Pharma, that have a lot of staff and experience with sBLA etc; so JNJ will be one of only a few that have a chance in my opinion, and Dara is their fastest growing drug, AND FDA has already goodplenty of experience with & and knowledge off Dara

[Solsen]

JW said today that two drugs was approved under RTOR up to now.

[Solsen]

Just heard the Børsen interview again. And no doubt that they are under RTOR review now. But there is a risk that they can be put to Priority review by FDA.

[Solsen]

Dara have 3% front line now and it could reach 10% by year end. Now we can begin calculate

[Solsen]

And my calculator says byond 200 dkk pr share - when dara reach +10bn uds

[Solsen]

If we listen carefully to JWs interview it seems that MRD measured on confirmed CRs could be the way to approval under RTOR....

[peter12]

2000,- I hope ?

[Solsen]

JW er ikke helt opdateret. Følgende er godkendt under RTOR: Kisqali, keytuda og som tidligere nævnt adcetris fra SGEN. Så mindst 3 tidligere approvals.

[Solsen]

Revenue from dara sales exceed 200 dkr pr share

[Helge_LarsenPI-redaktør]

Just a moment...

(www.proinvestor.com)

[Budweis]

Genmab Announces Submission of Supplemental New Drug Application for Daratumumab in Front Line Multiple Myeloma in Japan

[sowise]

https://borsen.dk/nyheder/virksomheder/artikel/1/373904/genmab_faar_milepaelsbetaling_paa_2_mio_dollar_for_tillaegsansoegning.html mon det giver en 5-10% i dag

[polle1]

Frisk bud, sowise, meeen mon dog ?
Godmorgen og god dag

[Hvidkær]

Et hus som jeg ikke kender så meget til - Zack - har løftet fra "strong sell" til "hold". Jf. pressoracle.com. Som jeg ikke kendte i forvejen.

[Helge_LarsenPI-redaktør]

Zack er vist bare en maskinopsamler af analyser.

[bibob]

God morgen fra Malaga. zack er skod.

[E_L]

"13/12 17:10
af Joakim Von And
could it be milestone tomorow??? " he was smart enough not to specify what milestone, so i think he wins first price today, congratulations Joakim

[Hvidkær]

Nyd dagen i Malaga - Zack er glemt

[Sukkeralf]

Medicinalfirmaer skrotter midler i stor stil: Omkostninger er blevet for store

Verdens største medicinalselskaber lukker programmer ned i deres forskningsafdelinger som sjældent set før, for omkostningerne har vokset sig så store, at selskaberne skal satse smalt og ikke bredt. Og det er en trend, som også Novo Nordisk er med på.

(medwatch.dk)

[Soeborg]

Zacks Research er en velkendt og anerkendt virksomhed beliggende i
USA